Find out how integrative chiropractic care combines innovative strategies with empathy to tackle Opioid Use Disorder effectively.
Opioid use disorder (OUD) is a chronic neurobiological condition. Medications for opioid use disorder (MOUD) remain the treatment with the strongest evidence for reducing overdose death. In a personal-injury clinic, a large share of opioid exposure starts somewhere else: a collision, a work injury, a disc herniation, sciatica, or months of guarded motion that were never rehabilitated. The opioid then becomes the coping strategy for a mechanical problem.
This educational post explains how integrative chiropractic care acts on the musculoskeletal system to interrupt that loop. Joint restoration, soft-tissue treatment, hip-hinge and core retraining, graded exposure, and pain neuroscience education reduce nociceptive input, rebuild load sharing, and lower the sympathetic arousal that amplifies both pain and craving. These services do not replace methadone, buprenorphine, or naltrexone. They reduce the biomechanical reasons patients reach for opioids and make it easier to stay in MOUD and rehabilitation.
Clinical observations from my practice, shared at personalinjurydoctorgroup.com and on LinkedIn, are paired with current public-health figures and peer-reviewed evidence. Medical safety, diagnostics, and medication management are overseen by our Medical Director, Dr. Maria Guadalupe Cardenas, MD, board-certified in internal medicine (NPI 1164426749; Texas MD License J2933).
Many patients I see in El Paso did not set out to develop OUD. They came for neck pain after a rear-end collision, lumbar pain after a lift at work, sacroiliac pain after a fall, or sciatica that started as a “pulled muscle.” Opioids were started for a real nociceptive injury. When the joint, disc, or nerve root was never restored, the prescription became the way to get through a shift.
That sequence is common in injury care. Whiplash leaves cervical segments hypomobile, and the deep neck flexors inhibited. A lumbar disc injury teaches the patient to avoid hip flexion, so the lumbar spine flexes instead. Facet irritation, sacroiliac asymmetry, and gluteal inhibition follow. Adjacent regions then hurt because the kinetic chain is compensating. Post-injury kinetic chain dysfunction is one of the most reliable patterns in our clinic: the original segment is restricted, and the pain shows up next door.
Pain of this kind is not only a local tissue event. Central sensitization, the amplification of pain signals in the spinal cord and brain, tracks with pain as a reason for starting opioids, continuing them, escalating the dose, delaying treatment, and relapsing (Hall et al., 2022). Chronic lumbar pain also feeds negative affect and broken sleep, and those two amplifiers raise craving risk. A patient who cannot lie down, drive, or work is a patient still organizing the day around the next dose. Public health numbers have improved, but they are still severe. Provisional data from the CDC National Center for Health Statistics estimate 69,973 drug overdose deaths in the United States in 2025, down almost 14% from 81,313 in 2024. Deaths involving opioids fell from an estimated 55,296 in 2024 to 44,564 in 2025 (Centers for Disease Control and Prevention [CDC], 2026). These counts are provisional. In the 2024 National Survey on Drug Use and Health, 4.8 million people aged 12 or older had a past-year opioid use disorder, and only 17% (about 818,000 people) received MOUD (Substance Abuse and Mental Health Services Administration [SAMHSA], 2025). Most people who meet criteria are untreated. An injury clinic that can treat the spine and coordinate medication in the same plan is positioned to intercept part of that gap before a short opioid course becomes a disorder.
OUD remakes how the musculoskeletal system moves, hurts, and heals. That’s why chiropractic care belongs in the plan.
Guarded motion and joint restriction. Pain teaches the nervous system to lock segments. Cervical facets stop gliding after whiplash. Lumbar segments stop extending. Hips stop hinging. The thorax stiffens. Patients stand with a flexed trunk, a short stride, and a braced jaw. That pattern unloads an irritable disc for a few minutes and overloads the same tissues for the rest of the day. Capsule thickening, muscle inhibition, and lost proprioception turn an acute injury into a chronic pain generator.
Peripheral and central sensitization. Injured discs, facet capsules, and paraspinal muscles release substance P, calcitonin gene-related peptide, tumor necrosis factor-alpha, interleukin-1 beta, and prostaglandin E2. Those mediators lower the firing threshold of A-delta and C fibers. Repeated C-fiber input opens NMDA channels in the dorsal horn, so the body reads ordinary touch and joint motion as pain. Opioid-induced hyperalgesia pushes the same system further: the drug that once relieved pain begins to heighten it, often with restlessness, myoclonus, and pain that spreads beyond the original injury (Hall et al., 2022).
Withdrawal myalgias and autonomic surge. Opioid withdrawal is a musculoskeletal event. Bone and joint aches, restless legs, sweating, tremor, and piloerection are scored on the Clinical Opiate Withdrawal Scale because they are reliable. Sympathetic overdrive tightens paraspinal, scalene, and jaw muscles, wrecks sleep, and makes craving feel physical. Patients often describe the urge to use as “my back is on fire” rather than as a thought.
Deconditioning. Sedation, poor sleep, and low protein intake strip the muscles that should brace the spine. Gluteal inhibition and a weak deep core leave the disc and facets taking load the hips should have shared. Falls from sedation add sprains and new prescriptions. In injury patients, this stacks on the original trauma, so the collision and the opioid are both still in the tissues months later.
Injection-related bone, joint, and soft-tissue injury. People who inject are at risk for septic arthritis, osteomyelitis, and abscess, often from Staphylococcus aureus, including MRSA. These are medical emergencies until infection is controlled. After antibiotic or surgical care, residual stiffness and gait change become rehabilitation problems. Xylazine, an alpha-2 adrenergic adulterant, adds ischemic skin necrosis that limits weight-bearing and shoulder or hip motion (Gupta et al., 2023). Naloxone does not reverse xylazine. Airway support still comes first.
Comorbid pain syndromes. Sciatica, cervical radiculopathy, sacroiliac pain, thoracic stiffness, and widespread nociplastic pain commonly travel with OUD. Depression, anxiety, post-traumatic stress, and trauma history travel with them. Untreated, each one is a relapse trigger. Treated, each one is a recovery milestone the patient can feel in a work task or a night of sleep.
In this model, chiropractic care is not a single thrust. It is a sequence aimed at the tissues that keep sending danger signals after an injury.
Joint motion. High-velocity, low-amplitude adjustments and slower mobilizations stimulate mechanoreceptors in the capsule and paraspinal muscles. Large-diameter afferents enter the dorsal horn and activate inhibitory interneurons that reduce C-fiber traffic, the gate-control effect described in the neurophysiology of spinal manipulation (Pickar, 2002). Restored segmental motion unloads a swollen facet, improves disc nutrition through movement, and gives the brain a position sense it had lost. That mechanoreceptor barrage can also engage descending inhibition from the periaqueductal gray and rostral ventromedial medulla. In whiplash and lumbar injury, the practical target is joint play: a segment that moves is a segment sending fewer danger signals.
Muscle, fascia, and nerve. Instrument-assisted soft-tissue work and trigger-point release reduce local chemical irritation. In sciatica, the problem is often both a lumbar segment and a tethered nerve. Neurodynamic glides reduce mechanical tension on the root without asking the patient to push through electric pain. Sacroiliac asymmetry is treated as a load-sharing problem between the pelvis and the hip, not as an isolated “pop.”
Motor control. In my experience, correcting hip-hinge mechanics and core control reduces lumbar pain more reliably than passive modalities alone. The hinge puts flexion in the hips. Bracing and gluteal activation share compression that would otherwise sit on the disc. Anti-rotation work stabilizes the lumbar-pelvic complex for lifting, which is the task that injured many of these patients in the first place. Short movement doses through the day sustain the change better than one hard session a week.
Autonomic tone. Withdrawal and chronic pain both raise sympathetic drive. Gentle thoracic mobilization, rib-cage motion, and paced breathing lower that drive. Patients stabilized on buprenorphine who add structured movement report faster gains in sleep and mood. I do not claim the adjustment treats insomnia or depression. I claim a stiff, sympathetic thorax is one reason these patients cannot downshift at night, and sleep is one of the strongest non-drug buffers against next-day pain and craving.
Pain neuroscience education and graded exposure. Explaining sensitization in plain language reduces catastrophizing. Graded exposure replaces the prediction that every bend will harm with new evidence from a task the patient values: playing with a child, finishing a shift, driving without a flare. Confidence in activity is a clinical outcome, not a slogan. It is also what keeps people in MOUD.
The evidence that this sequence lowers opioid exposure should be stated at its actual strength. Among New Hampshire adults with office visits for noncancer low back pain, receipt of chiropractic services was associated with a 55% lower likelihood of filling an opioid prescription (odds ratio 0.45; 95% CI 0.40-0.47) (Whedon et al., 2018). In active-duty service members, adding chiropractic care to usual medical care produced moderate short-term gains in pain and disability and lower self-reported pain-medication use at six weeks (odds ratio 0.73; 95% CI 0.54-0.97) (Goertz et al., 2018). A 2025 systematic review and meta-analysis found very low-certainty evidence that chiropractic care may reduce the odds of receiving prescription opioids for noncancer spine pain by about 64% (OR 0.36; 95% CI 0.25-0.52), with a larger association when care started within 30 days of presentation (Emary et al., 2025). Early musculoskeletal care appears to matter more than late care. These studies are mostly observational. They support chiropractic care as a way to reduce opioid exposure for spine pain. They do not show that adjustment treats OUD by itself.
MOUD is the mortality intervention. Methadone and buprenorphine are associated with substantially lower mortality during treatment than no medication or treatment stopped (Sordo et al., 2017). After a nonfatal overdose, methadone and buprenorphine are associated with lower all-cause and opioid-related mortality (Larochelle et al., 2018). Buprenorphine is a partial mu-opioid agonist with a ceiling on respiratory depression and a higher receptor affinity than most full agonists, which is why a stable dose can blunt the effect of relapsed fentanyl (SAMHSA, 2021). Office-based prescribing no longer requires an X-waiver (SAMHSA, 2023). Naltrexone blocks receptors without activating them, but it requires a full detoxification and carries a high overdose risk if it is stopped and use resumes (Lee et al., 2018).
Chiropractic care does not compete with that pharmacology. It handles the reason many injury patients say the medication is “not enough”: the neck, the back, the leg, the inability to work. In our clinic, the sequence is deliberate.
Safety first: naloxone in hand, fentanyl and xylazine risk discussed, infectious-disease screening, and no punitive response to a positive urine drug test.
MOUD selection and induction under Dr. Cardenas’s medical direction. For fentanyl-exposed patients, micro-induction is safer than a standard start, because fentanyl stored in fat raises the risk of precipitated withdrawal (Ahmed et al., 2021).
Hands-on care stays light during induction so we do not spike autonomic arousal.
As cravings settle, we add segmental care, hip-hinge drills, neurodynamic work, and graded strength aimed at the original injury task.
Personal-injury rehabilitation and OUD stabilization run on the same calendar, so the collision that started the opioid prescription is not left untreated while the medication is managed.
Withholding MOUD because a patient is still using is not harm reduction. Withholding rehabilitation because a patient is on buprenorphine is also a mistake.
These observations come from integrative injury care at Injury Medical Clinic PA and are discussed in the public clinical essays at personalinjurydoctorgroup.com and on my LinkedIn profile. They are practice patterns, not trial results.
Improving segmental mechanics and core endurance reduces pain catastrophizing, increases self-efficacy, and supports retention in MOUD. Medication and therapy adherence increases when pain falls, and sleep improves. Function usually improves before mood does. A patient who can hinge and walk symmetrically has new evidence that the body is recoverable, and that evidence supports the next buprenorphine dose and the next counseling visit.
The injury patterns repeat. Rear-end collisions leave cervical hypomobility, headache, and upper-limb paresthesia; restoring cervical and thoracic motion, then retraining deep neck flexors and posture, reduces the flare that patients had been covering with short-acting opioids. Work-related lumbar injuries respond better when hip-hinge mechanics and core control are corrected than when care stays passive. Sciatica after a disc injury becomes workable once OUD is stabilized: neurodynamic glides and segmental care can then reduce peripheral sensitization without a withdrawal spike. Sacroiliac pain after a fall or a motor-vehicle impact often quiets when pelvic load-sharing and gluteal activation are restored, which cuts the end-of-day flare that had been driving extra opioid use.
Patients stabilized on buprenorphine who engage in structured movement plans report faster improvements in sleep and mood. I use that as a timing rule. Micro-dosed movement during induction, then progressive loading once the dose is stable. Chronic lumbar pain that is left untreated keeps feeding negative affect and sleep disruption, and those two keep feeding craving. Treating the lumbar driver is relapse prevention, not an optional wellness add-on.
A recurring case shape is the laborer or driver with an unsettled injury and daily fentanyl exposure. Micro-induction, naloxone, and a low early dose come first. Breathing and non-provocative mobility come second. Spinal care, hip-hinge drills, and graded conditioning come third, aimed at tolerating a shift. The functional goal, not a pain score of zero, is what predicts retention.
Musculoskeletal comorbidities of OUD are not side issues.
Withdrawal myalgia eases when the dose is adequate and when paraspinal guarding is treated. Chiropractic care does not replace a correct buprenorphine or methadone dose.
Opioid-induced hyperalgesia is a signal to stop escalating full agonists and to rebuild descending inhibition with movement, education, and MOUD.
Treat deconditioning after injury with protein-adequate meals, daily walking, and progressive posterior-chain loading once infection and cardiac status are clear.
Manage post-infection stiffness after treated septic arthritis with rehabilitation, coordinated with the physician who cleared the patient.
Xylazine wounds need wound care first. We protect load-bearing areas around dressings. We do not mobilize through active necrosis.
Co-use of benzodiazepines and alcohol raises overdose risk. We do not add sedating techniques that leave a patient orthostatic.
Trauma, depression, and post-traumatic stress are named and referred. Manual care can lower bodily threat. It does not replace trauma-focused therapy.
Pregnancy changes tissue laxity and balance. Methadone and buprenorphine remain the pharmacologic standards (American College of Obstetricians and Gynecologists, 2017). Manual care stays gentle.
Harm reduction sits under all of this. Naloxone for every patient at risk, fentanyl test-strip education, coordination with syringe service programs, and the rule that a return to use is data, not discharge (Aspinall et al., 2014; National Harm Reduction Coalition, n.d.). Motivational interviewing, using open questions, affirmations, reflections, and summaries, is how we set the next mobility goal without a lecture (Miller & Rollnick, 2013). Relapse is a stage in a chronic illness, not a character failure (Prochaska & DiClemente, 1983).
Injury Medical Clinic PA is built so the injury plan and the medical plan meet. Dr. Cardenas provides diagnostic leadership, internal-medicine management, MOUD selection, EKG review before methadone, and infectious-disease screening. I provide the neuromusculoskeletal examination, chiropractic care, functional-medicine support, and rehabilitation direction, and I prescribe buprenorphine and naltrexone under that medical collaboration. Personal-injury rehabilitation, including spinal care, exercise, and, when appropriate, nonsurgical disc and nerve protocols, sits in the same pathway as medication. A patient does not have to choose between the back injury and the opioid disorder.
Chiropractic care does not reverse an overdose, occupy mu-opioid receptors, or substitute for methadone, buprenorphine, or naltrexone. It does not treat endocarditis, necrotizing infection, or pregnancy-related OUD without medical care. Observational associations between chiropractic visits and fewer opioid fills can be affected by who seeks that care. The honest claim is narrower and still clinically important: restoring joint motion, muscle capacity, nerve mobility, and autonomic balance removes musculoskeletal drivers of opioid use, lowers craving tied to pain flares, and makes MOUD and counseling easier to stay in. That is how chiropractic care reduces OUD risk in an integrative injury clinic. It treats the body that has been using opioids to solve a mechanical problem.
Ahmed, S., Bhivandkar, S., Lonergan, B. B., & Suzuki, J. (2021). Microinduction of buprenorphine/naloxone: A review of the literature. The American Journal on Addictions, 30(4), 305-315.
American College of Obstetricians and Gynecologists. (2017). Opioid use and opioid use disorder in pregnancy (Committee Opinion No. 711). Obstetrics & Gynecology, 130(2), e81-e94.
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Publishing.
Aspinall, E. J., Nambiar, D., Goldberg, D. J., Hickman, M., Weir, A., Van Velzen, E., Palmateer, N., Doyle, J. S., Hellard, M. E., & Hutchinson, S. J. (2014). Are needle and syringe programs associated with a reduction in HIV transmission among people who inject drugs: A systematic review and meta-analysis. International Journal of Epidemiology, 43(1), 235-248.
Centers for Disease Control and Prevention. (2026, May 13). U.S. overdose deaths decrease for third consecutive year in 2025. National Center for Health Statistics.
Emary, P. C., Corcoran, K. L., Coleman, B. C., Brown, A. L., Ciraco, C., DiDonato, J., Wang, L., Couban, R. J., Sud, A., & Busse, J. W. (2025). Impact of chiropractic care on opioid use for noncancer spine pain: Systematic review and meta-analysis. PAIN Reports, 11(1), e1374.
Goertz, C. M., Long, C. R., Vining, R. D., Pohlman, K. A., Walter, J., & Colter, I. (2018). Effect of usual medical care plus chiropractic care vs usual medical care alone on pain and disability among US service members with low back pain: A comparative effectiveness clinical trial. JAMA Network Open, 1(1), e180105.
Gupta, R., Holtgrave, D. R., & Ashburn, M. A. (2023). Xylazine: Medical and public health imperatives. The New England Journal of Medicine, 388(24), 2209-2212.
Hall, O. T., Teater, J., Rood, K. M., Phan, K. L., & Clauw, D. J. (2022). Central sensitization in opioid use disorder: A novel application of the American College of Rheumatology Fibromyalgia Survey Criteria. PAIN Reports, 7(4), e1016.
Jimenez, A. (n.d.). Clinical observations on personal injury, neuromusculoskeletal rehabilitation, and integrative pain care. Injury Medical Clinic PA.
Jimenez, A. (n.d.). Professional profile and clinical updates. LinkedIn.
Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., & Walley, A. Y. (2018). Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study. Annals of Internal Medicine, 169(3), 137-145.
Lee, J. D., Nunes, E. V., Jr., Novo, P., Bach, V., Bailey, G. L., Bhatt, S., & Rotrosen, J. (2018). Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X: B OT): A multicentre, open-label, randomized controlled trial. The Lancet, 391(10118), 309-318.
Miller, W. R., & Rollnick, S. (2013). Motivational interviewing: Helping people change (3rd ed.). Guilford Press.
National Harm Reduction Coalition. (n.d.). Overdose prevention. National Harm Reduction Coalition.
Pickar, J. G. (2002). Neurophysiological effects of spinal manipulation. The Spine Journal, 2(5), 357-371.
Prochaska, J. O., & DiClemente, C. C. (1983). Stages and processes of self-change of smoking: Toward an integrative model of change. Journal of Consulting and Clinical Psychology, 51(3), 390-395.
Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017). Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies. BMJ, 357, j1550.
Substance Abuse and Mental Health Services Administration. (2021). Medications for opioid use disorder (Treatment Improvement Protocol 63, Publication No. PEP21-02-01-002). U.S. Department of Health and Human Services.
Substance Abuse and Mental Health Services Administration. (2023). Waiver elimination (MAT Act). U.S. Department of Health and Human Services.
Substance Abuse and Mental Health Services Administration. (2025). Key substance use and mental health indicators in the United States: Results from the 2024 National Survey on Drug Use and Health (HHS Publication No. PEP25-07-007). Center for Behavioral Health Statistics and Quality.
Whedon, J. M., Toler, A. W. J., Goehl, J. M., & Kazal, L. A. (2018). Association between utilization of chiropractic services for treatment of low-back pain and use of prescription opioids. Journal of Alternative and Complementary Medicine, 24(6), 552-556.
opioid use disorder, OUD, chiropractic care, musculoskeletal pain, personal injury, whiplash, sciatica, sacroiliac pain, central sensitization, opioid-induced hyperalgesia, buprenorphine, methadone, naltrexone, MOUD, harm reduction, naloxone, low back pain, hip hinge, core control, neurodynamic glides, autonomic regulation, withdrawal myalgia, integrative rehabilitation, Injury Medical Clinic PA, El Paso Texas, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, non-opioid pain management, fentanyl, xylazine, pain neuroscience education, work injury, auto accident recovery